CHOP researchers Find NTRK fusions more common than expected in pediatric tumors

Philadelphia, January 14, 2021–In a large study of pediatric cancer patients, researchers from Children’s Hospital of Philadelphia (CHOP) have analyzed the frequency, fusion partners, and clinical outcome of neurotrophic tyrosine receptor kinase (NTRK) fusions, which are clinical biomarkers that identify patients suitable for treatment with FDA-approved TRK inhibitors. The researchers found that NTRK fusions are…

Graduate student groups from 15 states awarded for science policy initiatives to engage

Research!America and the Rita Allen Foundation are pleased to announce the recipients of the 2021 Civic Engagement Microgrant Initiative. Now in its third year, the microgrant program provides funding to graduate student and postdoc-led science policy groups from across the U.S. to develop and lead outreach activities in their local communities. The 2021 Civic Engagement…